Capreomycin sulfate: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Capreomycin is a [[peptide]] [[antibiotic]], commonly grouped with the [[aminoglycoside]]s, which is given in combination with other [[antibiotics]] for MDR-[[tuberculosis]]. Adverse effects include [[nephrotoxicity]] and 8th cranial auditory vestibular nerve [[neurotoxicity|nerve toxicity]]. | |||
==Category== | ==Category== | ||
Antimycobacterial | Antimycobacterial | ||
Revision as of 23:58, 25 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Capreomycin is a peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for MDR-tuberculosis. Adverse effects include nephrotoxicity and 8th cranial auditory vestibular nerve nerve toxicity.
Category
Antimycobacterial
US Brand Names
CAPASTAT SULFATE®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages